Ranexa

Medicinal product

(Invented) name

Ranexa

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

Menarini International Operations Luxembourg S.A., Liuksemburgas

Date of authorisation

2008-07-09

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
31221	33655	1033655	lizdinė plokštelė	N60	Receptinis	EU/1/08/462/001	Tiekiama	-	-	No	-	-
31222	33656	1033656	buteliukas	N60	Receptinis	EU/1/08/462/002	Netiekiama	-	-	No	-	-
42328	56094	1056094	lizdinė plokštelė	N30	Receptinis	EU/1/08/462/007	Netiekiama	-	-	No	-	-
42329	56095	1056095	lizdinė plokštelė	N100	Receptinis	EU/1/08/462/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2008-07-09	Registruotas